139 related articles for article (PubMed ID: 34416395)
21. PKPD modelling of PR and QRS intervals in conscious dogs using standard safety pharmacology data.
Bergenholm L; Collins T; Evans ND; Chappell MJ; Parkinson J
J Pharmacol Toxicol Methods; 2016; 79():34-44. PubMed ID: 26780675
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the sensitivity of a new fully implantable telemetry device and the importance of simultaneously measuring cardiac output and left ventricular pressure.
McKee J; Daller J; Baumgartner B; Pettinger S
J Pharmacol Toxicol Methods; 2014; 69(3):229-36. PubMed ID: 24468466
[TBL] [Abstract][Full Text] [Related]
23. An integrative pharmacokinetic-cardiovascular physiology modelling approach based on in vivo dog studies including five reference compounds.
Wallman M; Borghardt JM; Martel E; Pairet N; Markert M; Jirstrand M
J Pharmacol Toxicol Methods; 2022; 115():107171. PubMed ID: 35398273
[TBL] [Abstract][Full Text] [Related]
24. Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants.
Chui RW; Fosdick A; Conner R; Jiang J; Bruenner BA; Vargas HM
J Pharmacol Toxicol Methods; 2009; 60(1):58-68. PubMed ID: 19426820
[TBL] [Abstract][Full Text] [Related]
25. Echocardiographic and hemodynamic indices of myocardial contractility simultaneously evaluated in telemetered beagle dogs: A HESI-sponsored cross-company evaluation.
Rossman EI; Cools F; Cordes J; Dhuyvetter D; Doyle JM; Friedrichs GS; Guth B; Neradilek MB; Parish ST; Pierson JB; Polissar N; Tang HM
J Pharmacol Toxicol Methods; 2020 Sep; 105():106897. PubMed ID: 32663523
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the PhysioTel™ Digital M11 cardiovascular telemetry implant in socially housed cynomolgus monkeys up to 16weeks after surgery.
Andersen NK; Meyer O; Bradley A; Dragsted N; Lassen AB; Sjögren I; Larsen JM; Harvey W; Bator R; Milne A
J Pharmacol Toxicol Methods; 2017 Sep; 87():82-92. PubMed ID: 28416413
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of blood flow parameters in addition to blood pressure and electrocardiogram in the conscious telemetered beagle dog.
Taylor GL; Patel B; Sullivan AT
J Pharmacol Toxicol Methods; 2007; 56(2):212-7. PubMed ID: 17582788
[TBL] [Abstract][Full Text] [Related]
28. A canine model used to simultaneously assess potential neurobehavioural and cardiovascular effects of candidate drugs.
Tontodonati M; Fasdelli N; Moscardo E; Giarola A; Dorigatti R
J Pharmacol Toxicol Methods; 2007; 56(2):265-75. PubMed ID: 17587603
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular safety pharmacology studies in dogs enabled for a poorly soluble molecule using spray-dried dispersion: Impact on lead selection.
Tseng YC; Linehan B; Ng KJ; Smith DM; Markert M; Patel M; Guth B; Fryer RM
Int J Pharm; 2016 Oct; 512(1):137-146. PubMed ID: 27543349
[TBL] [Abstract][Full Text] [Related]
30. The impact of environmental and biological factors on the resting heart rate of dogs as assessed using 20 years of data from safety pharmacology studies.
Alizadeh EA; Trautmann T; Krause F; Knoeferl B; Guns PJ; De Meyer G; Guth BD; Markert M
J Pharmacol Toxicol Methods; 2023; 121():107263. PubMed ID: 36965603
[TBL] [Abstract][Full Text] [Related]
31. An integrative pharmacological approach to radio telemetry and blood sampling in pharmaceutical drug discovery and safety assessment.
Litwin DC; Lengel DJ; Kamendi HW; Bialecki RA
Biomed Eng Online; 2011 Jan; 10():5. PubMed ID: 21244682
[TBL] [Abstract][Full Text] [Related]
32. An improved method of electrode placement in configuration Lead II for the reliable ECG recording by telemetry in the conscious rat.
Tontodonati M; Fasdelli N; Dorigatti R
J Pharmacol Toxicol Methods; 2011; 63(1):1-6. PubMed ID: 20332033
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of moxifloxacin in canine and non-human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration-QTc analysis.
Chui RW; Baublits J; Chandra FA; Jones ZW; Engwall MJ; Vargas HM
Clin Transl Sci; 2021 Nov; 14(6):2379-2390. PubMed ID: 34173339
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry.
Takahara A; Dohmoto H; Yoshimoto R; Sugiyama A; Hashimoto K
Eur J Pharmacol; 2001 Feb; 413(1):101-8. PubMed ID: 11173068
[TBL] [Abstract][Full Text] [Related]
35. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model.
Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ
J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000
[TBL] [Abstract][Full Text] [Related]
36. The rat telemetry assay and venous catheter access buttons for use in cardiovascular safety pharmacology assessments - Surgical methods, refinements and colony maintenance.
Hale E; Storer D; Smith N; McCarthy A; Skinner M
J Pharmacol Toxicol Methods; 2024; 127():107517. PubMed ID: 38797367
[TBL] [Abstract][Full Text] [Related]
37. Drug-induced QT prolongation: Concordance of preclinical anesthetized canine model in relation to published clinical observations for ten CiPA drugs.
Koshman YE; Wilsey AS; Bird BM; Endemann AL; Sadilek S; Treadway J; Martin RL; Polakowski JS; Gintant GA; Mittelstadt SW
J Pharmacol Toxicol Methods; 2020; 103():106871. PubMed ID: 32360993
[TBL] [Abstract][Full Text] [Related]
38. Power spectral analysis of heart rate variability in cynomolgus monkeys in safety pharmacology studies: comparative study with beagle dogs.
Champeroux P; Martel E; Jude S; Laigot C; Laveissière A; Weyn-Marotte AA; Fowler JS; Maurin A; Richard S; Babuty D
J Pharmacol Toxicol Methods; 2013; 68(1):166-74. PubMed ID: 23435316
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: heart rate-dependent effects during sinus rhythm in conscious telemetered dogs.
Sällström J; Al-Saffar A; Pehrson R
J Pharmacol Toxicol Methods; 2014; 69(1):24-9. PubMed ID: 24140388
[TBL] [Abstract][Full Text] [Related]
40. Influence of surgically implantable telemetry solutions on in-life and post-mortem toxicology endpoints.
Baird TJ; Bailie M; Patrick DJ; Moddrelle D; Yoder J; Gauvin DV; Dalton JA
J Pharmacol Toxicol Methods; 2013; 67(3):148-61. PubMed ID: 23438450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
